Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cimetropium
2. Da 3177
3. Da-3177
4. Scopolamine N-(cyclopropylmethyl)bromide
1. Alginor
2. 51598-60-8
3. Cimetropium Bromide [inn]
4. 0c7m5we60q
5. Da-3177
6. [(1s,2s,4r,5r)-9-(cyclopropylmethyl)-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2s)-3-hydroxy-2-phenylpropanoate;bromide
7. Cimetropii Bromidum
8. Bromuro De Cimetropio
9. Bromure De Cimetropium
10. Cimetropii Bromidum [latin]
11. Unii-0c7m5we60q
12. Bromure De Cimetropium [french]
13. Bromuro De Cimetropio [spanish]
14. Schembl26842
15. Chembl2105977
16. Cimetropium Bromide [mi]
17. Cimetropium Bromide [jan]
18. Cimetropium Bromide [mart.]
19. Cimetropium Bromide [who-dd]
20. Hy-u00106
21. Cs-7142
22. Da 3177
23. 8-(cyclopropylmethyl)-6beta,7beta-epoxy-3alpha-((s)-tropoyl)-1alphah,5alphah-tropanium Bromid
24. 8-(cyclopropylmethyl)-6beta,7beta-epoxy-3alpha-hydroxy-1alphah,5alphah-tropanium Bromide, (-)-(s)-tropate
25. N-cyclopropylmethylscopolamine Bromide
26. (7(s)-(1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.))-9-(cyclopropylmethyl)-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-3-oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane Bromide
27. (7(s)-(1alpha,2beta,4beta,5alpha,7beta))-9-(cyclopropylmethyl)-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-3-oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane Bromide
28. 3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane, 9-(cyclopropylmethyl)-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, Bromide, (7(s)-(1alpha,2beta,4beta,5alpha,7beta))-
29. 3-oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 9-(cyclopropylmethyl)-7-((2s)-3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, Bromide (1:1), (1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)-
Molecular Weight | 438.4 g/mol |
---|---|
Molecular Formula | C21H28BrNO4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 7 |
Exact Mass | 437.12017 g/mol |
Monoisotopic Mass | 437.12017 g/mol |
Topological Polar Surface Area | 59.1 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 538 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
A - Alimentary tract and metabolism
A03 - Drugs for functional gastrointestinal disorders
A03B - Belladonna and derivatives, plain
A03BB - Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
A03BB05 - Cimetropium bromide
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
ABOUT THIS PAGE
42
PharmaCompass offers a list of Cimetropium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cimetropium manufacturer or Cimetropium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cimetropium manufacturer or Cimetropium supplier.
PharmaCompass also assists you with knowing the Cimetropium API Price utilized in the formulation of products. Cimetropium API Price is not always fixed or binding as the Cimetropium Price is obtained through a variety of data sources. The Cimetropium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bromuro de cimetropio manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bromuro de cimetropio, including repackagers and relabelers. The FDA regulates Bromuro de cimetropio manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bromuro de cimetropio API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bromuro de cimetropio manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bromuro de cimetropio supplier is an individual or a company that provides Bromuro de cimetropio active pharmaceutical ingredient (API) or Bromuro de cimetropio finished formulations upon request. The Bromuro de cimetropio suppliers may include Bromuro de cimetropio API manufacturers, exporters, distributors and traders.
click here to find a list of Bromuro de cimetropio suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Bromuro de cimetropio Drug Master File in Korea (Bromuro de cimetropio KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Bromuro de cimetropio. The MFDS reviews the Bromuro de cimetropio KDMF as part of the drug registration process and uses the information provided in the Bromuro de cimetropio KDMF to evaluate the safety and efficacy of the drug.
After submitting a Bromuro de cimetropio KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Bromuro de cimetropio API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Bromuro de cimetropio suppliers with KDMF on PharmaCompass.
A Bromuro de cimetropio written confirmation (Bromuro de cimetropio WC) is an official document issued by a regulatory agency to a Bromuro de cimetropio manufacturer, verifying that the manufacturing facility of a Bromuro de cimetropio active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Bromuro de cimetropio APIs or Bromuro de cimetropio finished pharmaceutical products to another nation, regulatory agencies frequently require a Bromuro de cimetropio WC (written confirmation) as part of the regulatory process.
click here to find a list of Bromuro de cimetropio suppliers with Written Confirmation (WC) on PharmaCompass.
Bromuro de cimetropio Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bromuro de cimetropio GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bromuro de cimetropio GMP manufacturer or Bromuro de cimetropio GMP API supplier for your needs.
A Bromuro de cimetropio CoA (Certificate of Analysis) is a formal document that attests to Bromuro de cimetropio's compliance with Bromuro de cimetropio specifications and serves as a tool for batch-level quality control.
Bromuro de cimetropio CoA mostly includes findings from lab analyses of a specific batch. For each Bromuro de cimetropio CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bromuro de cimetropio may be tested according to a variety of international standards, such as European Pharmacopoeia (Bromuro de cimetropio EP), Bromuro de cimetropio JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bromuro de cimetropio USP).